--- title: "United Laboratories International Holdings (3933) stock" url: "https://aibio.space/companies/united-laboratories-international/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "United Laboratories International Holdings Ltd. (HKEX: 3933), Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked." --- 3933 United Laboratories International Holdings Ltd. HKEX · Hong Kong # United Laboratories International Holdings (3933) news United Laboratories International Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3933, recorded under Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest United Laboratories International Holdings news We have not published a story on United Laboratories International Holdings yet. When there is news, it will appear here. ## United Laboratories International Holdings at a glance - **Ticker**: 3933 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [Wai Yuen Tong Medicine Holdings](https://aibio.space/companies/wai-yuen-tong-medicine/) HKEX: 897 - [PuraPharm Corp.](https://aibio.space/companies/purapharm/) HKEX: 1498 - [Extrawell Pharmaceutical Holdings](https://aibio.space/companies/extrawell-pharmaceutical/) HKEX: 858 - [Sino Biopharmaceutical](https://aibio.space/companies/sino-biopharmaceutical/) HKEX: 1177 - [Regencell Bioscience Holdings](https://aibio.space/companies/regencell-bioscience/) NASDAQ: RGC - [Beijing Tong Ren Tang Chinese Medicine Co.](https://aibio.space/companies/beijing-tong-ren-tang-chinese-medicine/) HKEX: 3613 - [HUTCHMED (China)](https://aibio.space/companies/hutchmed-china/) HKEX: 13 - [Shenzhen Neptunus Interlong Bio-Technique Co.](https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/) HKEX: 8329 ### Also on HKEX - [Wuhan YZY Biopharma Co.](https://aibio.space/companies/wuhan-yzy-biopharma/) 2496 - [Edding Genor Group Holdings](https://aibio.space/companies/edding-genor/) 6998 - [Luye Pharma Group](https://aibio.space/companies/luye-pharma/) 2186 - [Hanx Biopharmaceuticals (Wuhan) Co.](https://aibio.space/companies/hanx-biopharmaceuticals-wuhan/) 3378 - [CARsgen Therapeutics Holdings](https://aibio.space/companies/carsgen-therapeutics/) 2171 - [Suzhou Ribo Life Science Co.](https://aibio.space/companies/suzhou-ribo-life-science/) 6938 ## Questions about United Laboratories International Holdings What is the ticker symbol of United Laboratories International Holdings? United Laboratories International Holdings Ltd. trades under the ticker 3933 on HKEX. Where is United Laboratories International Holdings listed? United Laboratories International Holdings Ltd. is listed on HKEX. Our directory also records these other listings: GETTEX:UNJ; LS:A0MUFS; OTC:ULIHF. Which country or territory is United Laboratories International Holdings listed under? Our directory records United Laboratories International Holdings Ltd. under Hong Kong. What does United Laboratories International Holdings do? Our directory classifies United Laboratories International Holdings Ltd. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline. What is the ISIN of United Laboratories International Holdings? The ISIN recorded for United Laboratories International Holdings Ltd. is KYG8813K1085. Does aibio.space cover United Laboratories International Holdings? aibio.space lists United Laboratories International Holdings Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to United Laboratories International Holdings? Companies in our directory listed in the same country and business area as United Laboratories International Holdings: Wai Yuen Tong Medicine Holdings, PuraPharm Corp., Extrawell Pharmaceutical Holdings, Sino Biopharmaceutical, Regencell Bioscience Holdings, Beijing Tong Ren Tang Chinese Medicine Co.. ## Investor discussion: United Laboratories International Holdings Members talk about United Laboratories International Holdings (3933). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at United Laboratories International Holdings, newest first. Each line links the filing it comes from. 1. 2025-07-25 Financings Share or debt issue: COMPLETION OF PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0725/2025072501083.pdf) 2. 2025-07-18 Financings Share or debt issue: PLACING OF NEW SHARES UNDER THE GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0718/2025071800055.pdf) ## Press releases Headlines of United Laboratories International Holdings's own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-24 HKEXnews [SECOND MILESTONE PAYMENT FROM NOVO FOR EXCLUSIVE LICENSE AGREEMENT OF UBT251](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092402333.pdf) 2. 2026-09-24 HKEXnews [Notification Letter to Non-register Holder and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092401939.pdf) 3. 2026-09-24 HKEXnews [Notification Letter to Shareholder and Reply Form](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092401927.pdf) 4. 2026-09-24 HKEXnews [THE GROUP'S PRODUCT INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION MARKETING REGISTRATION APPLICATION BEEN ACCEPTED](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0924/2026092401885.pdf) 5. 2026-09-07 HKEXnews [UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR TYPE 2 DIABETES IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0907/2026090701245.pdf) 6. 2026-09-04 HKEXnews [UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR OVERWEIGHT OR OBESITY IN CHINA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0904/2026090401861.pdf) 7. 2026-09-03 HKEXnews [CLARIFICATION ANNOUNCEMENT TO 2026 INTERIM RESULTS ANNOUNCEMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0903/2026090302333.pdf) 8. 2026-08-31 HKEXnews [Interim Results Announcement For The Six Months Ended 30 June 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083103075.pdf) 9. 2026-08-19 HKEXnews [PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0819/2026081901011.pdf) 10. 2026-08-11 HKEXnews [FDA APPROVAL OF IND FOR THE GROUP'S PRODUCT UBT48128 TABLETS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0811/2026081100853.pdf) 11. 2026-07-16 HKEXnews [RECEIVED MILESTONE PAYMENT FROM NOVO NORDISK FOR EXCLUSIVE LICENSE AGREEMENT OF UBT251](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0716/2026071600152.pdf) 12. 2026-07-14 HKEXnews [APPROVAL FOR MARKETING OF THE GROUP'S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0714/2026071400932.pdf) 13. 2026-07-02 HKEXnews [APPROVAL FOR MARKETING OF THE GROUP'S PRODUCT TADALAFIL TABLETS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0702/2026070202806.pdf) 14. 2026-06-30 HKEXnews [RETIREMENT OF EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063001516.pdf) 15. 2026-06-30 HKEXnews [Final dividend for the year ended 31 December 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0630/2026063000639.pdf) 16. 2026-06-29 HKEXnews [PAYMENT OF 2025 FINAL DIVIDEND](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062902671.pdf) 17. 2026-06-23 HKEXnews [POLL RESULTS OF THE 2026 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0623/2026062301697.pdf) 18. 2026-06-11 HKEXnews [APPROVAL FOR CLINICAL TRIAL OF THE GROUP'S PRODUCT TUL321 CAPSULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0611/2026061101465.pdf) 19. 2026-06-11 HKEXnews [VOLUNTARY ANNOUNCEMENT PROPOSED SHARE BUY-BACK UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0611/2026061101347.pdf) 20. 2026-05-19 HKEXnews [APPROVAL FOR CLINICAL TRIAL OF GROUP'S PRODUCT TUL108 FOR INJECTION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0519/2026051901069.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:3933 on TradingView](https://www.tradingview.com/symbols/HKEX-3933/). ## Listing details United Laboratories International Holdings Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 3933, recorded under Hong Kong. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: United Laboratories International Holdings Ltd. - **Ticker**: 3933 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Biopharma / pharmaceutical profile checked - **ISIN**: KYG8813K1085 - **Other listed symbols**: GETTEX:UNJ; LS:A0MUFS; OTC:ULIHF - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-3933/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/united-laboratories-international/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "United Laboratories International Holdings (3933) stock", 2026-10-31, https://aibio.space/companies/united-laboratories-international/